|
1
|
Lathia JD, Mack SC, Mulkearns-Hubert EE,
Valentim CL and Rich JN: Cancer stem cells in glioblastoma. Genes
Dev. 29:1203–1217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim SS, Harford JB, Pirollo KF and Chang
EH: Effective treatment of glioblastoma requires crossing the
blood-brain barrier and targeting tumors including cancer stem
cells: The promise of nanomedicine. Biochem Biophys Res Commun.
468:485–489. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mirimanoff RO: High-grade gliomas: Reality
and hopes. Chin J Cancer. 33:1–3. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Grauer OM, Wesseling P and Adema GJ:
Immunotherapy of diffuse gliomas: Biological background, current
status and future developments. Brain Pathol. 19:674–693. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Patil SA, Hosni-Ahmed A, Jones TS, Patil
R, Pfeffer LM and Miller DD: Novel approaches to glioma drug design
and drug screening. Expert Opin Drug Discov. 8:1135–1151. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lujambio A and Lowe SW: The microcosmos of
cancer. Nature. 482:347–355. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sarkar FH, Li Y, Wang Z, Kong D and Ali S:
Implication of microRNAs in drug resistance for designing novel
cancer therapy. Drug Resist Updat. 13:57–66. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu X, Shen H, Yin X, Long L, Xie C, Liu
Y, Hui L, Lin X, Fang Y, Cao Y, et al: miR-186 regulation of Twist1
and ovarian cancer sensitivity to cisplatin. Oncogene. 35:323–332.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Erdmann K, Kaulke K, Thomae C, Huebner D,
Sergon M, Froehner M, Wirth MP and Fuessel S: Elevated expression
of prostate cancer-associated genes is linked to down-regulation of
microRNAs. BMC Cancer. 14:822014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cai J, Wu J, Zhang H, Fang L, Huang Y,
Yang Y, Zhu X, Li R and Li M: miR-186 downregulation correlates
with poor survival in lung adenocarcinoma, where it interferes with
cell-cycle regulation. Cancer Res. 73:756–766. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumor metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang X, Ling MT, Guan XY, Tsao SW, Cheung
HW, Lee DT and Wong YC: Identification of a novel function of
TWIST, a bHLH protein, in the development of acquired taxol
resistance in human cancer cells. Oncogene. 23:474–482. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maestro R, Dei Tos AP, Hamamori Y,
Krasnokutsky S, Sartorelli V, Kedes L, Doglioni C, Beach DH and
Hannon GJ: Twist is a potential oncogene that inhibits apoptosis.
Genes Dev. 13:2207–2217. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mikheeva SA, Mikheev AM, Petit A, Beyer R,
Oxford RG, Khorasani L, Maxwell JP, Glackin CA, Wakimoto H,
González-Herrero I, et al: TWIST1 promotes invasion through
mesenchymal change in human glioblastoma. Mol Cancer. 9:1942010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lan J, Xue Y, Chen H, Zhao S, Wu Z, Fang
J, Han C and Lou M: Hypoxia-induced miR-497 decreases glioma cell
sensitivity to TMZ by inhibiting apoptosis. FEBS Lett.
588:3333–3339. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang J, Wang W, Fang D, Jin X, Ding L and
Sun X: MicroRNA186 targets IGF-1R and exerts tumor-suppressing
functions in glioma. Mol Med Rep. 16:7821–7828. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Myatt SS, Wang J, Monteiro LJ, Christian
M, Ho KK, Fusi L, Dina RE, Brosens JJ, Ghaem-Maghami S and Lam EW:
Definition of microRNAs that repress expression of the tumor
suppressor gene FOXO1 in endometrial cancer. Cancer Res.
70:367–377. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Goeppert B, Schmezer P, Dutruel C, Oakes
C, Renner M, Breinig M, Warth A, Vogel MN, Mittelbronn M, Mehrabi
A, et al: Down-regulation of tumor suppressor A kinase anchor
protein 12 in human hepatocarcinogenesis by epigenetic mechanisms.
Hepatology. 52:2023–2033. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tan Z, Zhao J and Jiang Y: MiR-634
sensitizes glioma cells to temozolomide by targeting CYR61 through
Raf-ERK signaling pathway. Cancer Med. 7:913–921. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li FF, Xing C, Wu LL and Xue F: MiR-205
enhances cisplatin sensitivity of glioma cells by targeting E2F1.
Eur Rev Med Pharmacol Sci. 22:299–306. 2018.PubMed/NCBI
|
|
23
|
Kim J, Yoon H, Chung DE, Brown JL,
Belmonte KC and Kim J: miR-186 is decreased in aged brain and
suppresses BACE1 expression. J Neurochem. 137:436–445. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lei GS, Kline HL, Lee CH, Wilkes DS and
Zhang C: Regulation of Collagen V expression and
epithelial-mesenchymal transition by miR-185 and miR-186 during
idiopathic pulmonary fibrosis. Am J Pathol. 186:2310–2316. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee YH, Kim SY and Bae YS: Upregulation of
miR-760 and miR-186 is associated with replicative senescence in
human lung fibroblast cells. Mol Cells. 37:620–627. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee KE and Bar-Sagi D: Oncogenic KRas
suppresses inflammation-associated senescence of pancreatic ductal
cells. Cancer Cell. 18:448–458. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Beck B, Lapouge G, Rorive S, Drogat B,
Desaedelaere K, Delafaille S, Dubois C, Salmon I, Willekens K,
Marine JC and Blanpain C: Different levels of Twist1 regulate skin
tumor initiation, stemness, and progression. Cell Stem Cell.
16:67–79. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ansieau S, Morel AP, Hinkal G, Bastid J
and Puisieux A: TWISTing an embryonic transcription factor into an
oncoprotein. Oncogene. 29:3173–3184. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nordfors K, Haapasalo J, Makela K,
Granberg KJ, Nykter M, Korja M, Paavonen T, Haapasalo H and Soini
Y: Twist predicts poor outcome of patients with astrocytic glioma.
J Clin Pathol. 68:905–912. 2015. View Article : Google Scholar : PubMed/NCBI
|
